Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Classement en actions #13761
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Prix de l'action
$0.85814713
Dernière synchronisation: 2025-05-14
Capitalisation boursière
$463.40M
Changement (1 jour)
-2.52%
Changement (1 an)
0.00%
Pays
GB
Échange Alliance Pharma plc (APH)

Catégorie

Bénéfices pour Alliance Pharma plc (APH)
Bénéfices en Dec 2024 TTM : $-18.14M
Selon les derniers rapports financiers de Alliance Pharma plc, les bénéfices actuels de l'entreprise sont de $-18.14M. En 2023, l'entreprise a réalisé un bénéfice de $-62.12M, une diminution par rapport à celui de 2022 qui était de $6.30M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Alliance Pharma plc de 2001 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-18.14M 0.00%
2024 $-18.14M -70.79%
2023 $-62.12M -1,085.97%
2022 $6.30M -74.33%
2021 $24.55M 37.95%
2020 $17.80M -56.82%
2019 $41.21M 41.89%
2018 $29.04M -24.24%
2017 $38.34M 39.81%
2016 $27.42M 22.57%
2015 $22.37M 41.38%
2014 $15.82M -20.44%
2013 $19.89M 13.43%
2012 $17.53M 5.47%
2011 $16.62M -17.03%
2010 $20.03M 115.66%
2009 $9.29M 162.51%
2008 $3.54M -155.33%
2007 $-6.40M -762.99%
2006 $964.73K -15.19%
2005 $1.14M -128.40%
2004 $-4.01M 3,427.78%
2002 $-113.53K -162.31%
2001 $182.20K 0.00%
Bénéfices des entreprises similaires ou concurrentes